Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03981289 · ClinicalTrials.gov registry record
Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy (LGMD)
A clinical trial, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- 116
- Enrollment target
NCT03981289 is a clinical trial that has completed, run by Virginia Commonwealth University. The registered enrollment target is 116 participants.
The verdict
NCT03981289 has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- 116 participants
- Enrollment target
Study Summary
Limb Girdle Muscular Dystrophy comprise a group of disorders made up of over 30 mutations which share a common phenotype of progressive weakness of the shoulder and hip girdle muscles. While the individual genetic mutations are rare, as a cohort, LGMDs are one of the four most common muscular dystrophies. The overall goal of project 1 is to define the key phenotypes as measured by standard clinical outcome assessments (COAs) for limb girdle muscular dystrophies (LGMD) to hasten therapeutic development.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2019-06-14 |
| Est. Completion | 2025-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03981289
The ClinicalTrials.gov registry entry for NCT03981289 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03981289 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03981289 about?
NCT03981289 is a clinical study titled "Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy (LGMD)". Limb Girdle Muscular Dystrophy comprise a group of disorders made up of over 30 mutations which share a common phenotype of progressive weakness of the shoulder and hip girdle muscles. While the individual genetic mutations are rare, as a cohort, LGMDs are one of the four most common muscular dystro...
What is the current status of trial NCT03981289?
This trial is currently completed. The enrollment target is 116 participants. The study started on 2019-06-14. Estimated completion is 2025-06-30.
Who is sponsoring clinical trial NCT03981289?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.